Expert Analysis

Target's ERISA Win Doesn't Ax Tobacco Surcharge Questions

Though a Minnesota federal court's recent dismissal of a putative class action challenging Target's tobacco surcha... (more story)

How 'Most Favored Nation' Regime Affects Biopharma Deals

As M&A activity surges in the biopharma space, companies will need to account for the Trump administration's most-... (more story)

Where DOJ's Fraud Priorities Memo May Actually Matter

The U.S. Department of Justice’s recently released memo outlining priorities for its newly created fraud division ... (more story)

Deals & Corporate Governance More

Doctor Shorted Practice Co-Owner On Distributions, Suit Says

A Colorado ophthalmologist failed to pay the co-owner of his practice the full distribution amounts owed to that physician while overpaying himself, according to a lawsuit filed in state court.

Guardant Suits Against Tempus AI Clear Dismissal Bids

A Delaware federal judge has refused to throw out litigation accusing Tempus AI Inc. of infringing Guardant Health Inc. patents covering technology used to analyze cancer-related genetic data and help guide te... (more story)

GAO Says CMS Should Rethink $52M Task Order

The Centers for Medicare and Medicaid Services applied unstated evaluation criteria when passing on a company's $49 million offer to provide support services for a health care facility surveyor training progra... (more story)

Mich. Hospitals Defend CVS 340B Drug Savings Suit

University of Michigan Hospitals and Health Centers urged a Michigan federal judge Wednesday to preserve its suit claiming that CVS Health Corp. diverted millions of dollars earmarked for indigent healthcare t... (more story)

Bankrupt Villages Health System Agrees To $541.5M FCA Deal

Florida-based The Villages Health System has agreed to shell out more than $541.5 million to resolve allegations it violated the False Claims Act by submitting false diagnosis codes to get more money from Medi... (more story)

23andMe, Calif. Spar Over Data Claims In Bankruptcy Court

The bankruptcy trust for DNA testing company 23andMe and the state of California locked horns Tuesday over the debtor's plan to trim the size of claims that the state has asserted over a data breach in 2023.

Digital Health & Technology More

AbbVie 'Concocted' Cancer Drug IP Claims, Biotech Firm Says

Biotech firms ProfoundBio and Genmab urged a Seattle federal judge Thursday to throw out rival AbbVie's lawsuit accusing two of its former employees of taking trade secrets on cancer therapies to ProfoundBio, ... (more story)

NJ Says TikTok Is Withholding Key Child Usage Data

New Jersey urged a state judge to force TikTok to hand over detailed user engagement data the state said was essential in proving that the platform's design harmed children, accusing the company of months of e... (more story)

DaVita, Patients Get Early Nod In $15M Data Breach Deal

A Colorado federal judge has given the initial green light to DaVita Inc.'s proposed $15 million settlement with millions of past and present patients who claim the healthcare company didn't adequately protect... (more story)

Patients Drop Data Breach Suit Against Medical Billing Co.

A group of patients has dropped a lawsuit accusing a Georgia-based medical billing practice of failing to properly secure the personal information of patients and employees ahead of a September data breach.

UnitedHealthcare Beats User's Data Privacy Suit, For Good

UnitedHealthcare Services Inc. permanently beat a proposed class action alleging that its website's third-party tracking pixels shared information about its visitors, after a California federal judge said Wedn... (more story)

AI Chatbot's Medical Claims Highlight Enforcement Risks

The Pennsylvania State Board of Medicine's recent lawsuit against Character Technologies, arguing that an artificial intelligence chatbot engaged in the unlicensed practice of medicine, may provide other state... (more story)

Policy & Compliance More

Walmart Pays $50M To End DOJ's Suit Over Opioid Crisis

Walmart has agreed to pay $50 million to settle the U.S. Department of Justice's nearly 6-year-old lawsuit in Delaware federal court alleging the big-box retailer helped spur the nationwide opioid crisis by un... (more story)

Mylan, Lannett, Others Can't Split Up Humana Generics Trial

A Pennsylvania federal judge refused Friday to let Mylan, Lannett and other generic-drug makers split up Humana's looming price-fixing trial between liability and damages, preferring a single go in front of a ... (more story)

Medical Marijuana Industry Grapples With DEA's New Role

After years of allowing the state-sanctioned medical marijuana industry to operate without interference, the U.S. Drug Enforcement Administration is stepping in to regulate a drug it once treated exclusively a... (more story)

Fla. Says PBMs Fixed Prices For Prescription Drugs

Florida's attorney general on Thursday sued two competing pharmacy benefit managers for allegedly colluding to fix prescription drug reimbursement rates to pharmacies, which the state said threatens Floridians... (more story)

4 Arguments For Benefits Attys To Watch In September

The Fifth Circuit will weigh Louisiana's bid to block telehealth access to the abortion drug mifepristone, while the Fourth Circuit will hear Lockheed Martin's challenge to a trial court decision that kept a p... (more story)

PBMs Hammer Opioid Judge In Last-Ditch Gambit At 6th Circ.

An Ohio federal judge knowingly flouted a Sixth Circuit rebuke by forcing two of the largest remaining defendants in multidistrict opioid litigation to either "settle for enormous sums or litigate for years hu... (more story)